This study evaluated the accuracy of sonography in detecting abnormal ipsilateral axillary lymph nodes in women with breast cancer. The authors retrospectively reviewed the sonographic findings and surgical pathology reports of 71 women who were diagnosed with breast cancer by ultrasound-guided biopsies. Results found in 71 cases that the sonographic specificity was 82%, whereas the sensitivity was only 40%. In 8 of the 17 cases (47%), sonography was suspicious for cancer, and the final surgical pathology was malignant. In 42 of 54 cases (77%), sonography of the axilla was not suspicious, and the final axillary node surgical pathology was negative. In 12 cases, sonographic images of the lymph nodes appeared normal, whereas the surgical pathology of the axillary nodes demonstrated malignancy. Ultrasound imaging has a high specificity when evaluating axillary lymph nodes and can be recommended when a suspicious finding is detected in the breast during diagnostic breast sonographic examination.
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Key words: ultrasound, axilla, lymph node, breast, cancer, sonography Axillary lymph node status is important for staging and treatment planning in women with breast cancer. Many women undergo sentinel node biopsy and then proceed to axillary dissection if the sentinel node or nodes show malignancy. [1] [2] [3] Sonography and ultrasound-guided fine needle aspiration (USFNA) have increasingly been used to evaluate suspicious lymph nodes prior to the sentinel node procedure. If a malignant lymph node is diagnosed by USFNA, then the patient can avoid the sentinel node procedure and proceed to full axillary node dissection at the time of primary tumor surgical resection. It has previously been shown by Bonnema et al, 1 in their study of 148 patients, that sensitivity and specificity of axillary sonography for the detection of abnormal nodes can be as high as 87% and 56%, respectively. Their study used the evaluation of the lymph node length. In contrast, sensitivity and specificity were 36% and 95%, respectively, when the echo pattern of the lymph node was used. 1 Oruwari et al 2 in 2002 demonstrated that ultrasound (US) of the axilla was more accurate in staging the axilla than the preoperative clinical examination in a study involving 26 patients. The sensitivity of US was 91%, the specificity 100%, and the accuracy 92%. Sapino et al, 3 in their study of 298 patients, recommended that preoperative evaluation of the axilla by sonography should be used because of its low cost and high specificity.
Many diagnostic criteria have been used to identify abnormal lymph nodes, including the following: size, shape, focal doubling of the cortical thickness, and cortical morphology. Damera et al 4 used nodal shape, including longitudinal to transverse axis ratio of less than 2, and abnormal morphology of the cortex, particularly concentric or eccentric thickening to more than 2 mm, as the most reliable criteria in predicting malignancy. Sapino et al 3 considered nodes suspect when they had 2D enlargement imparting a rounded appearance to the lymph node, an echo-poor central hilus, and eccentricity of the nodal cortex. Deurloo et al 5 used maximum cortex thickness as the main feature to predict metastatic disease in a lymph node. The normal cortical thickness of a lymph node is 1 to 2 mm, and an abnormal lymph node generally has a thickness greater than 2.3 mm. They reported a sensitivity of 95% and a specificity of 44% using this criterion.
Shetty et al 6 used the following findings to describe abnormal axillary lymph nodes: size greater than 20 mm; absence of a fatty hilum; abnormal sonographic appearance of the cortex, which included diffuse or focal thickening of the cortex or abnormal echotexture; and round shape. Stavros et al 7 describe several findings that should be considered when assessing abnormal axillary lymph nodes. The first finding is enlarging diameter or size of the lymph node, which Stavros et al consider to be the least useful. The next findings include rounding shape, markedly hypoechoic cortex, and several morphologic abnormalities: uniform versus eccentric cortical thickening, uniform versus eccentric hilar compression, convex "rat bit" hilar displacement, hilar obliteration, and loss of echogenic outer capsule and angular margins. Stavros et al also state that the relationship between adjacent lymph nodes is important as metastatic involvement of lymph nodes tends to occur in a step-by-step process. Right-to-left symmetry or asymmetry should be considered along with color Doppler and pulsed-wave Doppler analysis of the waveform pattern. Often, a metastatic axillary lymph node will be fed by multiple vessels, and the pulsed-wave Doppler of the lymph node will be similar to the primary tumor. 7 The current retrospective study was performed to further explore the accuracy of sonography in detecting abnormal axillary lymph nodes in women with US-guided biopsy-proven breast cancer at our institution. In addition, the most common sonographic features of the suspicious lymph nodes examined during this time period are described.
Materials and Methods
The Institutional Review Committee on Human Research approved this retrospective review. From January 1, 2002, through December 31, 2002, 141 invasive breast malignancies were confirmed on biopsy. Ninety-four (66%) were diagnosed with US-guided biopsy and 47 (33%) with stereotactic vacuum-assisted biopsy procedures. The sonographic findings and pathology reports of the 94 women who were diagnosed with invasive breast cancer by US-guided biopsies were retrospectively reviewed. Of the 94 cases, 23 were excluded from the study for the following reasons: no axillary lymph node dissection (12 cases); axilla not evaluated with US (4 cases); patient did not have surgery due to extensive metastatic disease, poor health, age, or declined surgery (5 cases); and lost to follow-up (2 cases). The sonographic examinations and biopsies were performed with a Linear Matrix 13-MHz transducer on a General Electric Logiq 700 US system (General Electric Medical Systems, Waukesha, WI).
As per our department protocol, a minimum of three gray-scale images of the axillary lymph nodes were taken during the initial diagnostic sonography examination. Each patient was initially scanned by an experienced breast sonographer, and then most of the cases were also scanned by a radiologist specializing in breast imaging. Images were taken at three axillary levels: inferior, mid, and superior. These three axillary levels were arbitrarily judged by the sonographer and radiologist performing the examination. Color and spectral Doppler evaluations of lymph nodes were generally not obtained. The sonographic criteria used by our practice, during this time period, to classify suspicious lymph nodes were as follows: change of shape from oval to round, loss of the central fatty hilum, thickened cortex, and/or irregular, bulbous cortex or enlarged lymph node when the cortex is thickened. If an abnormal axillary lymph node was observed, then additional images and measurements were obtained. We distinguished the axillary lymph nodes from intramammary lymph nodes by observing the axillary anatomy. Axillary lymph nodes were adjacent to the pectoralis muscle and axillary artery and vein. Intramammary lymph nodes were contained within breast tissue. We routinely image other nodal chains during our examinations but limited this study to the axillary lymph node chain.
One experienced breast sonographer reviewed the US reports, and if the axilla was not examined, the case was excluded from the study. At the time of report review, the sonographer made a notation of the descriptors used by the radiologist when describing the axillary lymph node(s). We routinely perform USFNA on all suspicious axillary lymph nodes discovered during sonographic examination. The USFNA is performed at the time of the USguided core biopsy of the suspicious breast mass. In our retrospective review of these cases, not all of the suspicious axillary lymph nodes had a USFNA at the time of the US-guided core biopsy of the suspicious breast mass. The main reason for this was that the radiologist performing the US-guided core biopsy decided that he or she did not think the lymph node looked abnormal.
All 71 women underwent axillary node dissection for final pathologic evaluation of lymph node status; some women also underwent sentinel lymph node biopsy. All final pathology reports were reviewed to determine axillary lymph node status.
Results
Of the 71 women in this study who had axillary sonography, 17 had suspicious axillary lymph nodes by sonographic criteria, whereas only 8 of the 17 (47%) had metastases detected in the axillary lymph nodes. The remaining 9 had no evidence of metastatic nodal disease on final surgical pathology. Fifty-four women had negative axillary sonography; 12 (22%) of these women had metastatic disease identified, and 42 (78%) had no evidence of metastatic nodal disease on final surgical pathology. None of the women in this retrospective study received neoadjuvant chemotherapy prior to their surgery. Table 1 summarizes our accuracy in determining axillary lymph node status during the study time period. For 10 of these 12 cases, the metastatic focus size was 5 mm or less on final surgical pathology.
The largest metastatic focus detected in the sonography-negative and sonography-suspicious cases is presented in Tables 2 and 3, respectively.
We believe that sonography was not able to resolve the pathologically detected and reported metastases in the axillary lymph nodes that were less than 5 mm in greatest dimension (10 cases). Therefore, we recalculated sensitivity and specificity for the 61 patients with negative nodes or metastases larger than 5 mm for comparison. Table  4 summarizes and compares our initial results with 71 patients to our recalculated results with 61 patients. This recalculation of the data was also performed to assist us in making a standard sonographic criterion of suspicious axillary lymph nodes to be applied by our institution. We also reviewed the descriptors of the suspicious axillary nodes used by the radiologists in the US report. Thickened, prominent, and bulbous were terms most often used when describing the lymph node cortex. Enlarged, hypoechoic, and loss of fatty hilum were used when describing the overall lymph node. Table 5 summarizes the descriptors used by the radiologists for the 17 lymph nodes interpreted as abnormal. Seven of the 8 (88%) malignant lymph nodes were characterized using the lymph node cortex descriptions of thickened, prominent, and bulbous. The remaining malignant lymph node (12%) was described as enlarged, with a loss of fatty hilum. Four of the 9 (44%) benign lymph nodes were described using the lymph node cortex descriptions of thickened, prominent, and bulbous. Five of the 9 (56%) benign lymph nodes were described using whole lymph node descriptors such as enlarged or loss of fatty hilum.
The final surgical pathology reports for the benign axillary lymph nodes did not reveal other benign neoplasms or nonbreast malignancies. Included are three examples of axillary lymph nodes we retrospectively reviewed during this time period. Figure 1 is a normal axillary lymph node with a thin cortex and normal fatty hilum. Figure 2 is an axillary lymph node with a thickened, bulbous cortex that partially replaces the fatty hilum. Figure  3 is an axillary lymph node with a thickened cortex that is displacing the fatty hilum.
TABLE 2. Summary of Largest Metastatic Nodal Focus From Surgical Pathology for Cases With a Normal Sonogram

Discussion
When compared to previously published literature on the subject, the current series was not as sensitive in detecting abnormal axillary lymph nodes. However, previous studies with higher sensitivity and specificity approached the sonographic evaluation of the axilla in a different manner. For example, Damera et al 4 performed a careful scan of the lower axilla posterior to where the pectoralis major muscle crosses the cranial edge of the breast disc, which is a common location of the sentinel node. They also measured the longitudinal and transverse dimensions to determine the axis ratio of a lymph node. If the axis ratio was < 2, then the node was considered suspicious. In addition, they determined that a lymph node with a concentrically or eccentrically thickened cortex > 2 mm should be considered suspicious. In their study, sensitivity was 55%, specificity was 82%, positive predictive value was 74%, and negative predictive value was 65%.
In 2002, Bedrosian et al 8 noted that the published sensitivity of US in the detection of nodal metastases in breast cancer ranged from 50% to 87% depending on the specific criteria used to define suspicious nodes. When using high-resolution US, with or without USFNA, published sensitivity ranges from 50% to 92%, specificity ranges from 90% to 100%, and accuracy ranges from 76% to 92%. 1, 4, [8] [9] [10] [11] [12] [13] Our sensitivity and specificity were lower than expected based on published series. Factors contributing to the lower than expected values may be small metastatic foci detected or confirmed with immunohistochemical stains. In 12 cases in which sonography of the lymph nodes appeared negative, the final surgical pathology was positive. For 10 of the 12 cases, the metastatic focus size was 5 mm or less on final surgical pathology. One of the 10 cases was read suspicious for metastasis due to a bulbous cortex and was subsequently found to have a .8-mm metastatic focus. This case should be considered a "lucky find" and would have a good chance of falling into the false-negative category normally, based on its size. Because the detection threshold of axillary lymph node sonography is unknown, we decided on an arbitrary threshold of 5 mm or less. We believe that sonography was not able to resolve the less than 5-mm metastases in the axillary lymph nodes that were reported on our final surgical pathology specimens. We would expect sonography to resolve a focus in the range of 5 to 8 mm in an axillary lymph node. Furthermore, it would be unlikely that the lymph nodes with metastatic focus sizes of less than 5 mm could be accurately biopsied with an USFNA. Table 2 summarizes the size of the malignant lymph node metastases for all 12 cases with a normal axillary lymph node sonography. Table 3 summarizes the largest metastatic focus for the eight cases with suspicious sonography. All but one of these cases had a malignant focus size of 5 mm or greater. This one case is the "lucky find" we described earlier, which had a .8-mm metastatic focus. Figure 4 is a sonographic image of an axillary lymph node with a 7-mm metastatic focus. This reinforces our expectations that sonography should resolve 5-to 8-mm metastatic foci in an axillary lymph node, if a careful examination is performed.
When we exclude the 10 cases in which the lymph node focus sizes were less than 5 mm and recalculate our sensitivity and specificity with a new total of 61 patients, our sensitivity increased to 80%. To our knowledge, the prognostic value of reporting small metastatic foci in the final surgical report is still unknown, and further study is needed. Table 4 summarizes and compares our initial results with 71 patients to our recalculated results with 61 patients.
We are aware that there is institutional variation in how the axilla is evaluated. This ranges from no sonographic evaluation at all to detailed examinations with nodal measurements, color Doppler, and pulse-waved Doppler examinations. Our institution falls in the middle of this range. We have been performing this examination more than five years and had never evaluated our performance. The widespread use of sentinel node biopsies led us to consider the impact of the presurgical evaluation of the axilla with breast sonography. Currently, we use sonographic evaluation in the setting of a highly suspicious breast mass, but we do not perform detailed measurements or Doppler evaluation. Since reviewing our sensitivity and specificity results, we have changed our protocol to include a measurement of the maximum lymph node cortex thickness, and this may improve performance characteristics of the US axillary lymph node examination. Addition of this criterion is based on the recommendation of Damera et al, 4 who defined a concentrically or eccentrically thickened cortex with a thickness > 2 mm as suspicious. The eight true positive lymph nodes we found had descriptors that focused on a description of the cortex, such as thickened, prominent, or bulbous. Upon review of these lymph nodes, in all cases, the cortical thickness was > 2 mm. In addition, breast imaging specialists will use more descriptors in their reporting of abnormal axillary lymph nodes. The objective for these changes is to improve our sensitivity for the diagnosis of abnormal axillary lymph nodes so that USFNA can be performed prior to surgery. Ultimately, we hope to observe a decreased frequency of axillary dissection after sentinel node biopsy due to pathologically positive sentinel nodes following false-negative sonography examination. Sonography has a high specificity when evaluating axillary lymph nodes and can be recommended when findings highly suggestive of malignancy are detected in the breast during diagnostic breast examination; however, small metastatic foci less than 5 mm are unlikely to be detected by diagnostic sonography of the axilla. Due to the small number of patient cases that were available for this study, these results are only descriptive of those patients reviewed. Although encouraging, this type of study warrants replication with larger numbers of cases to make generalizations to the larger population.
